In patients with peripheral artery disease but no diabetes, metformin did not improve 6-minute walk distance or any other ...

Although getting to a comfortable retirement is often a top financial goal for physicians, retirement planning can be a ...

In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Colleen Dawkins, FNP-C, RD, CSOWM ...

Referring families to the 211 community resource hotline nearly doubled the odds that toddlers would be enrolled in ...

After assessing data from the first 46 adults with refractory nontuberculous mycobacterial lung disease who completed the ...

A short sleep health intervention for children with acute lymphoblastic leukemia could lead to a substantial decrease in the ...

Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded ...

In this video from the American Academy of Ophthalmology meeting, Kenneth C. Fan, MD, MBA, highlights outcomes of the STARLIGHT study in Stargardt disease.

In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, discusses the real-world use of aflibercept 8 mg in wet age-related macular degeneration or diabetic macular edema.

In this video from the American Academy of Ophthalmology meeting, Philip J. Ferrone, MD, discusses the TEASE-2 trial results in treating Stargardt disease with gildeuretinol.

Non-physicians are behind more social media videos tagged under asthma and alpha-gal syndrome, according to data from two studies presented at the American College of Allergy, Asthma & Immunology ...

At 2 years, Black and white patients who received Lucentis for the treatment of diabetic macular edema achieved similar ...